International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.08 and traded as high as $0.10. International Stem Cell shares last traded at $0.06, with a volume of 7,000 shares trading hands.
International Stem Cell Price Performance
The company’s 50-day moving average is $0.07 and its 200-day moving average is $0.08.
International Stem Cell (OTCMKTS:ISCO – Get Free Report) last posted its earnings results on Tuesday, August 13th. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $2.33 million for the quarter.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Featured Articles
- Five stocks we like better than International Stem Cell
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- MarketBeat Week in Review – 11/4 – 11/8
- What Are Dividend Achievers? An Introduction
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
